Tim Watkins, CMO & Head of Development at Contineum Therapeutics, Inc. (CTNM), sold 7,222 shares at $15.02 ($108K) on 2026-03-02, disclosed to the SEC on 2026-03-02.
Open-market sale of $108k CTNM by CMO & Head of Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.02 | 3,611 | $54K | 50.0% |
| 2 | $15.02 | 3,611 | $54K | 50.0% |
| Total | $15.02 avg | 7,222 | $108K | 100% |
| Filing → |
| CTNM | SELL | 2025-12-30 | $44K | — | Filing → |